{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T23:15:02Z","timestamp":1785798902651,"version":"3.56.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T00:00:00Z","timestamp":1746662400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100018553","name":"Science and Technology Plan Project of Wenzhou Municipality","doi-asserted-by":"publisher","award":["Y2023161"],"award-info":[{"award-number":["Y2023161"]}],"id":[{"id":"10.13039\/501100018553","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018553","name":"Science and Technology Plan Project of Wenzhou Municipality","doi-asserted-by":"publisher","award":["Y20220186"],"award-info":[{"award-number":["Y20220186"]}],"id":[{"id":"10.13039\/501100018553","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017594","name":"Medical Science and Technology Project of Zhejiang Province","doi-asserted-by":"publisher","award":["2022KY199"],"award-info":[{"award-number":["2022KY199"]}],"id":[{"id":"10.13039\/501100017594","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017594","name":"Medical Science and Technology Project of Zhejiang Province","doi-asserted-by":"publisher","award":["2024KY141"],"award-info":[{"award-number":["2024KY141"]}],"id":[{"id":"10.13039\/501100017594","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.bbadis.2025.167897","type":"journal-article","created":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T17:17:31Z","timestamp":1746724651000},"page":"167897","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["The potential biological function of STARD8 in prostate cancer: A bioinformatic and experimental validation study"],"prefix":"10.1016","volume":"1871","author":[{"given":"Zichuang","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeying","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaying","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaoyue","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiqing","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiliang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunbei","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2025.167897_bb0005","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1097\/JU.0000000000003452","article-title":"Updates to advanced prostate cancer: AUA\/SUO Guideline (2023)","volume":"209","author":"Lowrance","year":"2023","journal-title":"J. Urol."},{"key":"10.1016\/j.bbadis.2025.167897_bb0010","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27175730","article-title":"Prostate cancer review: genetics, diagnosis, treatment options, and alternative approaches","volume":"27","author":"Sekhoacha","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.bbadis.2025.167897_bb0015","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.semcancer.2021.11.001","article-title":"Understanding and targeting prostate cancer cell heterogeneity and plasticity","volume":"82","author":"Tang","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.bbadis.2025.167897_bb0020","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1159\/000519861","article-title":"Metastatic prostate cancer: treatment options","volume":"100","author":"Achard","year":"2022","journal-title":"Oncology"},{"issue":"3","key":"10.1016\/j.bbadis.2025.167897_bb0025","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24032939","article-title":"Mechanisms of prostate cancer cell survival and their therapeutic targeting","volume":"24","author":"Pejcic","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbadis.2025.167897_bb0030","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.path.2022.08.002","article-title":"Molecular genetics of prostate cancer and role of genomic testing","volume":"15","author":"Akhoundova","year":"2022","journal-title":"Surg. Pathol. Clin."},{"key":"10.1016\/j.bbadis.2025.167897_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2021.107932","article-title":"Prostate cancer biomarkers: from diagnosis to prognosis and precision-guided therapeutics","volume":"228","author":"Adamaki","year":"2021","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bbadis.2025.167897_bb0040","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14030596","article-title":"Metabolic phenotyping in prostate cancer using multi-omics approaches","volume":"14","author":"Gomez-Cebrian","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbadis.2025.167897_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118376","article-title":"An overview of advances in multi-omics analysis in prostate cancer","volume":"260","author":"Zhang","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.bbadis.2025.167897_bb0050","doi-asserted-by":"crossref","first-page":"4580","DOI":"10.1038\/sj.onc.1210244","article-title":"Deleted in liver cancer 3 (DLC-3), a novel Rho GTPase-activating protein, is downregulated in cancer and inhibits tumor cell growth","volume":"26","author":"Durkin","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.bbadis.2025.167897_bb0055","first-page":"4881","article-title":"High expression of DLC family proteins predicts better prognosis and inhibits tumor progression in NSCLC","volume":"19","author":"Sun","year":"2019","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.bbadis.2025.167897_bb0060","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.7150\/thno.29538","article-title":"Gastric cancer cells escape metabolic stress via the DLC3\/MACC1 axis","volume":"9","author":"Lin","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.bbadis.2025.167897_bb0065","first-page":"763","article-title":"Deleted in liver cancer protein family in human malignancies (review)","volume":"2","author":"Lukasik","year":"2011","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.bbadis.2025.167897_bb0070","first-page":"1224","article-title":"DLC-3 suppresses cellular proliferation, migration, and invasion in triple-negative breast cancer by the Wnt\/beta-catenin pathway","volume":"12","author":"Kong","year":"2019","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.bbadis.2025.167897_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.155000","article-title":"Regional bias of tumor suppressor gene mutations of STARD8 and WNK2 in colon cancers","volume":"253","author":"Mo","year":"2024","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.bbadis.2025.167897_bb0080","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.2147\/OTT.S154524","article-title":"Downregulation of STARD8 in gastric cancer and its involvement in gastric cancer progression","volume":"11","author":"Zhang","year":"2018","journal-title":"Onco. Targets. Ther."},{"key":"10.1016\/j.bbadis.2025.167897_bb0085","doi-asserted-by":"crossref","DOI":"10.1038\/oncsis.2012.13","article-title":"The RhoGAP protein deleted in liver cancer 3 (DLC3) is essential for adherens junctions integrity","volume":"1","author":"Holeiter","year":"2012","journal-title":"Oncogenesis"},{"key":"10.1016\/j.bbadis.2025.167897_bb0090","doi-asserted-by":"crossref","first-page":"3583","DOI":"10.1242\/jcs.190074","article-title":"The polarity protein scribble positions DLC3 at adherens junctions to regulate Rho signaling","volume":"129","author":"Hendrick","year":"2016","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.bbadis.2025.167897_bb0095","doi-asserted-by":"crossref","first-page":"9012","DOI":"10.1073\/pnas.0703033104","article-title":"Oncogenic inhibition by a deleted in liver cancer gene requires cooperation between tensin binding and Rho-specific GTPase-activating protein activities","volume":"104","author":"Qian","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2025.167897_bb0100","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.bbrc.2007.10.052","article-title":"START-GAP3\/DLC3 is a GAP for RhoA and Cdc42 and is localized in focal adhesions regulating cell morphology","volume":"364","author":"Kawai","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbadis.2025.167897_bb0105","doi-asserted-by":"crossref","first-page":"3355","DOI":"10.1111\/febs.14195","article-title":"Focal adhesions: a personal perspective on a half century of progress","volume":"284","author":"Burridge","year":"2017","journal-title":"FEBS J."},{"key":"10.1016\/j.bbadis.2025.167897_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2021.110046","article-title":"Focal adhesion dynamics in cellular function and disease","volume":"85","author":"Mishra","year":"2021","journal-title":"Cell. Signal."},{"key":"10.1016\/j.bbadis.2025.167897_bb0115","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.223172","article-title":"DLC3 suppresses MT1-MMP-dependent matrix degradation by controlling RhoB and actin remodeling at endosomal membranes","volume":"132","author":"Noll","year":"2019","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.bbadis.2025.167897_bb0120","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1146\/annurev-cellbio-111315-125227","article-title":"Cellular and molecular mechanisms of MT1-MMP-dependent cancer cell invasion","volume":"32","author":"Castro-Castro","year":"2016","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"10.1016\/j.bbadis.2025.167897_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154087","article-title":"A chalcone-syringaldehyde hybrid inhibits triple-negative breast cancer cell proliferation and migration by inhibiting CKAP2-mediated FAK and STAT3 phosphorylation","volume":"101","author":"Jin","year":"2022","journal-title":"Phytomedicine"},{"key":"10.1016\/j.bbadis.2025.167897_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107700","article-title":"Discovery of pyrimidine-2,4-diamine analogues as efficiency anticancer drug by targeting GTSE1","volume":"151","author":"Xing","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bbadis.2025.167897_bb0135","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1080\/14728222.2023.2293757","article-title":"Novel signatures of prostate cancer progression and therapeutic resistance","volume":"27","author":"Wang","year":"2023","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.bbadis.2025.167897_bb0140","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/0955-0674(95)80112-X","article-title":"Adhesion in cell migration","volume":"7","author":"Huttenlocher","year":"1995","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.bbadis.2025.167897_bb0145","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/nrc3792","article-title":"FAK in cancer: mechanistic findings and clinical applications","volume":"14","author":"Sulzmaier","year":"2014","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbadis.2025.167897_bb0150","doi-asserted-by":"crossref","first-page":"3318","DOI":"10.2174\/0929867327666201103162239","article-title":"New insights on Fak and Fak inhibitors","volume":"28","author":"Brullo","year":"2021","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.bbadis.2025.167897_bb0155","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.drup.2004.06.004","article-title":"Prediction of drug sensitivity and drug resistance in cancer by transcriptional and proteomic profiling","volume":"7","author":"Alaoui-Jamali","year":"2004","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.bbadis.2025.167897_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2023.110918","article-title":"PROS1, a clinical prognostic biomarker and tumor suppressor, is associated with immune cell infiltration in breast cancer: a bioinformatics analysis combined with experimental verification","volume":"112","author":"He","year":"2023","journal-title":"Cell. Signal."},{"key":"10.1016\/j.bbadis.2025.167897_bb0165","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/s12885-024-11913-7","article-title":"Unveiling promising breast cancer biomarkers: an integrative approach combining bioinformatics analysis and experimental verification","volume":"24","author":"Golestan","year":"2024","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bbadis.2025.167897_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.ygeno.2024.110800","article-title":"Identification of STAT3 as a biomarker for cellular senescence in liver fibrosis: a bioinformatics and experimental validation study","volume":"116","author":"Pang","year":"2024","journal-title":"Genomics"},{"key":"10.1016\/j.bbadis.2025.167897_bb0175","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/j.cmet.2021.04.002","article-title":"Mechanoresponsive metabolism in cancer cell migration and metastasis","volume":"33","author":"Zanotelli","year":"2021","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbadis.2025.167897_bb0180","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1111\/j.1582-4934.2007.00098.x","article-title":"DLC-1:a Rho GTPase-activating protein and tumour suppressor","volume":"11","author":"Durkin","year":"2007","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.bbadis.2025.167897_bb0185","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13046-018-0694-6","article-title":"14, 15-EET induces breast cancer cell EMT and cisplatin resistance by up-regulating integrin alphavbeta3 and activating FAK\/PI3K\/AKT signaling","volume":"37","author":"Luo","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.bbadis.2025.167897_bb0190","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/s41568-021-00340-6","article-title":"Targeting FAK in anticancer combination therapies","volume":"21","author":"Dawson","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbadis.2025.167897_bb0195","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1136\/gutjnl-2022-327927","article-title":"FAK suppresses antigen processing and presentation to promote immune evasion in pancreatic cancer","volume":"73","author":"Canel","year":"2023","journal-title":"Gut"}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443925002455?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443925002455?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T06:29:49Z","timestamp":1762324189000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443925002455"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":39,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S0925443925002455"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2025.167897","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The potential biological function of STARD8 in prostate cancer: A bioinformatic and experimental validation study","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2025.167897","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"167897"}}